UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
676
Texas Pacific Land
TPL
$22.8B
| $195M | 0.02% |
445,744
-27,863
| -6% | -$11.3M |
2014 Q4
46 quarters
|
|
677
Cincinnati Financial
CINF
$28.2B
| $195M | 0.02% |
1,050,678
+254,753
| +32% | +$42.2M |
2014 Q4
46 quarters
|
|
678
VictoryShares Free Cash Flow ETF
VFLO
$12.4B
| $194M | 0.02% |
4,249,954
+646,573
| +18% | +$28.1M |
2024 Q4
6 quarters
|
|
679
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12.1B
| $194M | 0.02% |
3,460,672
-49,842
| -1% | -$2.7M |
2014 Q4
46 quarters
|
|
680
Acuity Brands
AYI
$9.9B
| $194M | 0.02% |
515,771
+291,113
| +130% | +$86.3M |
2014 Q4
46 quarters
|
|
681
Cboe Global Markets
CBOE
$36.4B
| $194M | 0.02% |
800,010
+153,809
| +24% | +$47.1M |
2014 Q4
46 quarters
|
|
682
PUT
iShares Semiconductor ETF
SOXX
$41.8B
| $194M | 0.02% |
302,500
+291,000
| +2,530% | +$148M |
2025 Q1
5 quarters
|
|
683
PUT
Apollo Global Management
APO
$70.5B
| $194M | 0.02% |
1,637,500
+203,300
| +14% | +$25.6M |
2022 Q2
16 quarters
|
|
684
Expedia Group
EXPE
$35.9B
| $193M | 0.02% |
753,650
-250,119
| -25% | -$59.4M |
2014 Q4
46 quarters
|
|
685
First Trust Institutional Preferred Securities and Income ETF
FPEI
$1.86B
| $193M | 0.02% |
9,981,464
+184,115
| +2% | +$3.54M |
2017 Q4
34 quarters
|
|
686
CALL
Array Technologies
ARRY
$585M
| $192M | 0.02% |
25,977,000
+7,000,000
| +37% | +$55.8M |
2024 Q1
9 quarters
|
|
687
USA Rare Earth Inc
USAR
$3.33B
| $192M | 0.02% |
8,913,844
+5,030,029
| +130% | +$115M |
2024 Q1
9 quarters
|
|
688
Vulcan Materials
VMC
$37.1B
| $192M | 0.02% |
651,816
+201,556
| +45% | +$57.8M |
2014 Q4
46 quarters
|
|
689
Capital Group International Focus Equity ETF
CGXU
$6.38B
| $192M | 0.02% |
5,549,938
+221,264
| +4% | +$7.35M |
2022 Q2
16 quarters
|
|
690
Idexx Laboratories
IDXX
$52.9B
| $192M | 0.02% |
364,663
+59,496
| +19% | +$33.4M |
2014 Q4
46 quarters
|
|
|
691
PUT
ExxonMobil
XOM
$733B
| $191M | 0.02% |
1,400,500
-941,100
| -40% | -$141M |
2014 Q4
46 quarters
|
|
692
CALL
Charles Schwab
SCHW
$153B
| $191M | 0.02% |
2,073,600
+1,582,500
| +322% | +$144M |
2018 Q4
30 quarters
|
|
693
Vanguard Long-Term Corporate Bond ETF
VCLT
$7.71B
| $191M | 0.02% |
2,541,754
+134,416
| +6% | +$10.1M |
2014 Q4
46 quarters
|
|
694
Novo Nordisk
NVO
$178B
| $191M | 0.02% |
3,984,940
-580,768
| -13% | -$25M |
2014 Q4
46 quarters
|
|
695
CenterPoint Energy
CNP
$28.3B
| $190M | 0.02% |
4,307,806
+1,471,629
| +52% | +$63M |
2014 Q4
46 quarters
|
|
696
CALL
JD.com
JD
$35.5B
| $189M | 0.02% |
7,431,020
+851,700
| +13% | +$25.1M |
2016 Q2
40 quarters
|
|
697
Ametek
AME
$55.5B
| $189M | 0.02% |
781,244
-545,951
| -41% | -$126M |
2014 Q4
46 quarters
|
|
698
Clorox
CLX
$10.9B
| $189M | 0.02% |
1,980,435
+1,066,071
| +117% | +$102M |
2014 Q4
46 quarters
|
|
699
Alnylam Pharmaceuticals
ALNY
$21.2B
| $189M | 0.02% |
627,004
+168,134
| +37% | +$50.7M |
2014 Q4
46 quarters
|
|
700
Rivian
RIVN
$19.3B
| $189M | 0.02% |
10,870,671
+613,391
| +6% | +$9.6M |
2021 Q4
18 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.